Discontinued — last reported Q4 '22
Interest Income
Royalty Pharma Interest Income decreased by 11.9% to $6.23M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 44.8%, from $11.29M to $6.23M. Over 4 years (FY 2021 to FY 2025), Interest Income shows a downward trend with a -11.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher interest income suggests a strong cash position or a favorable interest rate environment for the company's investments.
Detailed definition
Interest income is the revenue earned from cash deposits, marketable securities, and other interest-bearing investments....
Peer comparison
Varies based on cash management strategies; companies with large cash piles will report higher interest income than those with high debt.
interest_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.04M | $12.26M | $10.64M | $9.53M | $10.92M | $14.03M | $43.85M | $16.70M | $25.65M | $23.44M | $6.50M | $7.42M | $13.38M | $17.51M | $9.04M | $11.29M | $8.33M | $6.90M | $7.07M | $6.23M |
| QoQ Change | — | -12.7% | -13.2% | -10.4% | +14.6% | +28.5% | +212.5% | -61.9% | +53.6% | -8.6% | -72.3% | +14.1% | +80.4% | +30.8% | -48.4% | +24.9% | -26.2% | -17.1% | +2.4% | -11.9% |
| YoY Change | — | — | — | — | -22.2% | +14.5% | +312.2% | +75.3% | +134.9% | +67.0% | -85.2% | -55.6% | -47.8% | -25.3% | +39.0% | +52.2% | -37.8% | -60.6% | -21.8% | -44.8% |
Interest Income at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's interest income?
- Royalty Pharma (RPRX) reported interest income of $6.23M in Q1 2026.
- How has Royalty Pharma's interest income changed year-over-year?
- Royalty Pharma's interest income decreased by 44.8% year-over-year, from $11.29M to $6.23M.
- What is the long-term trend for Royalty Pharma's interest income?
- Over 4 years (2021 to 2025), Royalty Pharma's interest income has grown at a -11.0% compound annual growth rate (CAGR), from $53.54M to $33.59M.
- What does interest income mean?
- The money earned from interest on cash holdings and investments.